0001610717-23-000215.txt : 20230721 0001610717-23-000215.hdr.sgml : 20230721 20230721173253 ACCESSION NUMBER: 0001610717-23-000215 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230719 FILED AS OF DATE: 20230721 DATE AS OF CHANGE: 20230721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saxonov Serge CENTRAL INDEX KEY: 0001786720 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39035 FILM NUMBER: 231103390 MAIL ADDRESS: STREET 1: 10X GENOMICS, INC. STREET 2: 6230 STONERIDGE MALL ROAD CITY: PLEASANTON STATE: CA ZIP: 94588 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 10x Genomics, Inc. CENTRAL INDEX KEY: 0001770787 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 455614458 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6230 STONERIDGE MALL ROAD CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: (925) 401-7300 MAIL ADDRESS: STREET 1: 6230 STONERIDGE MALL ROAD CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: 10X Genomics, Inc. DATE OF NAME CHANGE: 20190315 4 1 form4.xml X0508 4 2023-07-19 0001770787 10x Genomics, Inc. TXG 0001786720 Saxonov Serge 10X GENOMICS, INC. 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588 true true Chief Executive Officer true Class A Common Stock 2023-07-19 4 M 0 20845 5.04 A 909850 D Class A Common Stock 2023-07-19 4 S 0 40000 60.0272 D 869850 D Class A Common Stock 27 I See footnote Class A Common Stock 870 I See footnote Class A Common Stock 183350 I See footnote Class A Common Stock 16320 I See footnote Stock Option (right to buy) 5.04 2023-07-19 4 M 0 20845 0 D 2028-11-02 Class A Common Stock 20845 32478 D The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022. This transaction was executed in multiple trades at prices ranging from $60.00 to $60.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee. The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee. The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee. The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee. All of the shares subject to the option are fully vested and exercisable as of the date hereof. /s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov 2023-07-21